# A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma

> **NCT00930514** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 281 (actual)

## Conditions studied

- Lymphoma, Follicular

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Rituximab
- **DRUG:** Rituximab
- **DRUG:** Rituximab
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00930514
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930514, "A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00930514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*